Janney Montgomery Scott
ESPR

Janney Montgomery Scott’s Esperion Therapeutics ESPR Stock Holding History

Janney Montgomery Scott’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Buy
+22,051
New +$61.7K ﹤0.01% 3080
2026
Q1 		– Sell
-12,050
Closed -$45K – 2838
2025
Q4 		$45K Hold
12,050
– – ﹤0.01% 2892
2025
Q3 		$32K Hold
12,050
– – ﹤0.01% 2838
2025
Q2 		$12K Sell
12,050
-500
-4% -$501 ﹤0.01% 2692
2025
Q1 		$18K Sell
12,550
-9,000
-42% -$16.6K ﹤0.01% 2650
2024
Q4 		$47K Buy
21,550
+3,000
+16% +$7K ﹤0.01% 2656
2024
Q3 		$31K Buy
18,550
+5,000
+37% +$10.1K ﹤0.01% 2626
2024
Q2 		$30K Buy
+13,550
New +$31.9K ﹤0.01% 2571

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Janney Montgomery Scott's ESPR Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in Esperion Therapeutics (ESPR) in Q2 2026: 22,051 shares worth $70K. The stake represents ﹤0.01% of the portfolio and ranks #3080 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in ESPR as recently as Q4 2025.

Janney Montgomery Scott first reported a position in ESPR in Q2 2024 and has held it in 8 quarters since. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Janney Montgomery Scott held 22,051 shares of Esperion Therapeutics worth $70K as of Q2 2026.
  • Esperion Therapeutics was a new Janney Montgomery Scott position in Q2 2026.
  • Esperion Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #3080 holding.
  • Janney Montgomery Scott first reported a position in Esperion Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.